NATIONALITY
United States
EDUCATION
- MSc, Electrical Engineering, Michigan State University
- PhD, Computer Engineering, Michigan State University
- Graduate, Program on Negotiation, Harvard Law School
- Graduate, Leader Lab, Center for Creative Leadership
- Graduate, Manager of the Future and Leadership and Management in Action, JMW
PROJECTS
Dr. Asif Naseem joined PDS as President and CEO in December 2014 and is responsible for establishing and executing the company strategy. He was an M+Visión Visiting Fellow from September – December 2014.
He has held executive management roles at large public companies and small and medium privately held companies, including multiple startups. Prior to joining PDS, he served as Vice President, Communications Global Business Unit for the Oracle Corporation, where he was responsible for growing the telecom infrastructure equipment and services business for network equipment and service providers. Before joining Oracle, Asif served as President and Chief Operating Officer of GoAhead Software, Inc., a telecom infrastructure software company that was acquired by Oracle. Previously, Asif led the operations at Iospan Wireless, a broadband wireless company that was acquired by Intel Corporation.
Asif’s experience also includes executive management roles at AT&T Bell Laboratories, AT&T-NCR and Motorola, where he established and ran successful software, systems and applications businesses. He lived in Europe for several years while working as a general manager in the Internet and Connectivity Solutions Division for Motorola, where he was responsible for establishing and running the software applications business for large telecom operators and enterprises in Europe, the Middle East and Africa (EMEA). In addition to operational experience, Asif has successfully led several national and international mergers and acquisitions.
In M+Visión, Asif was a member of the 2014 cohort of Catalyst Fellows, working closely with them to identify unmet medical needs that could be solved with innovative technologies. He helped to form, and remains involved in, Team Skin, which is developing a new technology to help primary care providers make more critical decisions about which potential melanoma patients should be referred to specialists.
Access to M+Visión’s Faculty, both in Boston and in Madrid, and the hands on need identification process, drew Asif to the program. “The M+Visión program is a great opportunity to help expand my context for putting together product and service strategies for the healthcare market, both here and abroad,” he noted.
